Przejdź do treści
Kategoria

Tesamorelin

28 artykułów

Tesamorelin5 min czytania

What happens when Tesamorelin is stopped?

After discontinuing tesamorelin therapy, many individuals gradually regain visceral belly fat and may lose some of the metabolic benefits achieved during treatment, as […] decreases after therapy ends.

Tesamorelin5 min czytania

Why does Tesamorelin cause water retention?

Tesamorelin can cause water retention as it stimulates the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) pathway, which affects how sodium, fluids and tissue hydration are regulated...

Tesamorelin8 min czytania

Tesamorelin reduces visceral fat by mimicking the action of growth hormone-releasing hormone (GHRH). This stimulates the pituitary gland to release growth hormone (GH). GH, in turn, influences the liver to produce insulin-like growth factor 1 (IGF-1). Both GH and IGF-1 play a role in lipolysis, the breakdown of fat. Specifically, in the context of visceral fat, tesamorelin has been shown in clinical studies to lead to a significant reduction in visceral adipose tissue in individuals with HIV-associated lipodystrophy.

Tesamorelin reduces visceral fat by increasing the body's natural production of growth hormone (GH) through the activation of growth hormone-releasing hormone (GHRH) receptors in the pituitary gland. Along with…

BioEvidenceHub
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.